Manifestation of a cancer-associated TIF-1 gamma dermatomyositis after COVID-19 vaccine.
作者信息
Ooi Xue Ting, Choi Ellie Ce, Lee Joyce Ss
机构信息
Division of Dermatology, University Medicine Cluster, National University Hospital, Singapore.
Dermatology, National Skin Centre, Singapore.
出版信息
Int J Dermatol. 2022 Nov;61(11):1425-1426. doi: 10.1111/ijd.16358. Epub 2022 Jul 14.
Abstract
摘要
相似文献
1
Manifestation of a cancer-associated TIF-1 gamma dermatomyositis after COVID-19 vaccine.
Int J Dermatol. 2022 Nov;61(11):1425-1426. doi: 10.1111/ijd.16358. Epub 2022 Jul 14.
2
A case of Anti-MDA5-Positive dermatomyositis after inactivated COVID-19 vaccine.
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e127-e129. doi: 10.1111/jdv.18653. Epub 2022 Oct 31.
3
Appearance of anti-MDA5 antibody-positive dermatomyositis after COVID-19 vaccination.
Mod Rheumatol Case Rep. 2023 Jan 3;7(1):108-112. doi: 10.1093/mrcr/rxac064.
4
Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.
BMC Cancer. 2016 Aug 25;16(1):684. doi: 10.1186/s12885-016-2715-1.
5
Disease flare in patients with dermatomyositis following COVID-19 vaccination.
J Am Acad Dermatol. 2022 Dec;87(6):1373-1374. doi: 10.1016/j.jaad.2022.07.010. Epub 2022 Jul 9.
6
Vaccine-induced dermatomyositis following COVID-19 vaccination.
Dermatol Ther. 2022 Oct;35(10):e15749. doi: 10.1111/dth.15749. Epub 2022 Aug 18.
7
Antimelanoma Differentiation-Associated Gene 5 Antibody-Positive Interstitial Lung Disease After Vaccination With COVID-19 mRNA Vaccines.
J Rheumatol. 2022 Oct;49(10):1158-1162. doi: 10.3899/jrheum.220259. Epub 2022 Jun 15.
8
Dermatomyositis following COVID-19 vaccination.
Dermatol Ther. 2022 Jun;35(6):e15479. doi: 10.1111/dth.15479. Epub 2022 Apr 7.
9
Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.
Br J Dermatol. 2019 Apr;180(4):881-887. doi: 10.1111/bjd.17098. Epub 2018 Oct 10.
10
Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis.
Acta Derm Venereol. 2019 Mar 1;99(3):256-262. doi: 10.2340/00015555-3091.
引用本文的文献
1
Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports.
Rheumatol Int. 2024 Oct;44(10):2185-2196. doi: 10.1007/s00296-024-05683-5. Epub 2024 Aug 27.
2
Inflammatory myopathy following coronavirus disease 2019 vaccination: A systematic review.
Front Public Health. 2022 Oct 21;10:1007637. doi: 10.3389/fpubh.2022.1007637. eCollection 2022.
本文引用的文献
1
Two cases of anti-TIF1-γ antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination.
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e517-e520. doi: 10.1111/jdv.18060. Epub 2022 Mar 17.
2
Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine.
JAAD Int. 2022 Mar;6:107-108. doi: 10.1016/j.jdin.2021.12.009. Epub 2021 Dec 28.
3
Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180. doi: 10.1111/jdv.17744. Epub 2021 Nov 2.
4
Dermatomyositis: Clinical features and pathogenesis.
J Am Acad Dermatol. 2020 Feb;82(2):267-281. doi: 10.1016/j.jaad.2019.06.1309. Epub 2019 Jul 4.
Zotero 插件